Cargando…
Macrophage activation syndrome and pulmonary arterial hypertension in a patient with adult-onset Still disease: A case report
INTRODUCTION: Macrophage activation syndrome (MAS) and pulmonary arterial hypertension (PAH) are rare and life-threatening complications of adult-onset Still disease (AOSD). PATIENT CONCERNS: We reported an interesting case of a 25-year-old AOSD patient with MAS and PAH, and the patient was found to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946370/ https://www.ncbi.nlm.nih.gov/pubmed/31689747 http://dx.doi.org/10.1097/MD.0000000000017427 |
Sumario: | INTRODUCTION: Macrophage activation syndrome (MAS) and pulmonary arterial hypertension (PAH) are rare and life-threatening complications of adult-onset Still disease (AOSD). PATIENT CONCERNS: We reported an interesting case of a 25-year-old AOSD patient with MAS and PAH, and the patient was found to have right anomalous pulmonary venous connection accompanied by an atrial septal defect. DIAGNOSIS: MAS was diagnosed as a complication of AOSD. PAH was contributed probably by right anomalous pulmonary venous connection. INTERVENTIONS: The patient dramatically improved with methylprednisolone (80 mg I.V. daily) plus supportive treatments, without interleukin (IL) inhibitors or ciclosporin A given. OUTCOMES: The patient's serum hepatic enzyme levels dropped and hemocytes rose within 1 week. CONCLUSION: Other causes need to be excluded carefully before giving a diagnosis of PAH with AOSD. Early diagnosis and aggressive treatments are pivotal to improve the quality of life and the survival of patients. |
---|